Daiken Biomedical Co., Ltd. (TPE:7780)
Taiwan flag Taiwan · Delayed Price · Currency is TWD
208.50
+18.50 (9.74%)
At close: Sep 12, 2025

Daiken Biomedical Revenue

Daiken Biomedical had revenue of 454.88M TWD in the quarter ending June 30, 2025, with 60.46% growth. This brings the company's revenue in the last twelve months to 1.63B, up 31.96% year-over-year. In the year 2024, Daiken Biomedical had annual revenue of 1.36B with 14.45% growth.

Revenue (ttm)
1.63B
Revenue Growth
+31.96%
P/S Ratio
8.53
Revenue / Employee
n/a
Employees
n/a
Market Cap
13.89B

Revenue Chart

Revenue History

Fiscal Year EndRevenueChangeGrowth
Dec 31, 20241.36B171.97M14.45%
Dec 31, 20231.19B305.45M34.52%
Dec 31, 2022884.97M--

Revenue Definition

Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.

Full Definition